#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	976	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1113	47.1	0	.	p	.	0	K29T	NONSYN	85	87	AAG	287	289	ACG	54;55;54	A;C;G	54;55;54	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	506	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	144	41.6	0	.	n	.	0	T879G	SNP	879	879	T	20	20	G	2	G	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	506	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	144	41.6	0	.	n	.	0	G880A	SNP	880	880	G	21	21	A	2	A	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	506	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	144	41.6	0	.	n	.	0	A888G	SNP	888	888	A	29	29	G	6	G	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	506	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	144	41.6	0	.	n	.	0	C897G	SNP	897	897	C	38	38	G	15	G	15	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	506	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	144	41.6	0	.	n	.	0	T898C	SNP	898	898	T	39	39	C	16	C	16	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	506	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	144	41.6	0	.	n	.	0	G906T	SNP	906	906	G	47	47	T	36	T	36	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	506	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	144	41.6	0	.	n	.	0	G908A	SNP	908	908	G	49	49	A	39	A	39	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	506	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	144	41.6	0	.	n	.	0	A918T	SNP	918	918	A	59	59	T	42	T	42	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	506	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	144	41.6	0	.	n	.	0	A943G	SNP	943	943	A	84	84	G	89	G	89	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	506	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	144	41.6	0	.	n	.	0	G991T	SNP	991	991	G	132	132	T	54	T	54	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3620	Escherichia_coli_EF_Tu	1230	1209	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1448	125.4	1	SNP	p	R234F	1	.	.	700	702	TTC	939	941	TTC	169;168;160	T;T;C	169;168;160	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3620	Escherichia_coli_EF_Tu	1230	1209	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1448	125.4	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1239	1241	CGT	167;176;175	C;G;T	164;174;174	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3620	Escherichia_coli_EF_Tu	1230	1209	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1448	125.4	0	HET	.	.	.	T999C	.	999	999	T	1238	1238	T	157	T,C	84,73	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3620	Escherichia_coli_EF_Tu	1230	1209	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1448	125.4	0	HET	.	.	.	T180C	.	180	180	T	419	419	T	101	T,C	66,29	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3620	Escherichia_coli_EF_Tu	1230	1209	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1448	125.4	0	HET	.	.	.	C261T	.	261	261	C	500	500	C	138	C,T	91,44	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3620	Escherichia_coli_EF_Tu	1230	1209	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1448	125.4	0	HET	.	.	.	C144T	.	144	144	C	383	383	C	108	C,T	71,36	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3620	Escherichia_coli_EF_Tu	1230	68	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.2	209	20.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1718	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1726	53.4	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1248	1250	GAA	48;51;51	G;A;A	48;51;51	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	346	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	912	20.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	T1041G	SNP	1041	1041	T	12	12	G	165	G	111	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	A1042T	SNP	1042	1042	A	13	13	T	171	T	117	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	A1136G	SNP	1136	1136	A	107	107	G	256	G	253	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	T1138C	SNP	1138	1138	T	109	109	C	246	C	246	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	T1142C	SNP	1142	1142	T	113	113	C	224	C	223	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	C1170T	SNP	1170	1170	C	141	141	T	222	T	222	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	T1220C	SNP	1220	1220	T	191	191	C	224	C	224	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	T1245C	SNP	1245	1245	T	216	216	C	191	C	190	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	G1253A	SNP	1253	1253	G	224	224	A	202	A	202	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	G1256A	SNP	1256	1256	G	227	227	A	203	A	202	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	C1258A	SNP	1258	1258	C	229	229	A	213	A	212	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	G1266T	SNP	1266	1266	G	237	237	T	204	T	201	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	T1267C	SNP	1267	1267	T	238	238	C	201	C	200	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	T1275C	SNP	1275	1275	T	246	246	C	190	C	190	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	G1276A	SNP	1276	1276	G	247	247	A	187	A	187	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	A1281G	SNP	1281	1281	A	252	252	G	179	G	179	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	T1283C	SNP	1283	1283	T	254	254	C	182	C	180	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	G1288T	SNP	1288	1288	G	259	259	T	188	T	187	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	A1296G	SNP	1296	1296	A	267	267	G	228	G	227	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	T1299G	SNP	1299	1299	T	270	270	G	244	G	244	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	A1300T	SNP	1300	1300	A	271	271	T	250	T	249	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	C1356T	SNP	1356	1356	C	327	327	T	265	T	264	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	A1358G	SNP	1358	1358	A	329	329	G	247	G	246	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	T1368C	SNP	1368	1368	T	339	339	C	195	C	195	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	G1370A	SNP	1370	1370	G	341	341	A	178	A	178	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	C1406.	DEL	1406	1406	C	376	376	C	87	C	87	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	.1409C	INS	1409	1409	T	380	380	C	80	C	80	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	C1431A	SNP	1431	1431	C	402	402	A	8	A	8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	C1432A	SNP	1432	1432	C	403	403	A	8	A	8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	A1441G	SNP	1441	1441	A	412	412	G	6	G	6	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	T1464C	SNP	1464	1464	T	435	435	C	32	C	32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	G1473T	SNP	1473	1473	G	444	444	T	100	T	100	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	A1475G	SNP	1475	1475	A	446	446	G	112	G	111	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	.	n	.	0	A1548T	SNP	1548	1548	A	519	519	T	102	T	101	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	1	SNP	n	C1194G	0	.	.	1194	1194	C	165	165	C	229	C	229	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.3	553	211.9	0	HET	.	.	.	C1040T	.	1040	1040	T	11	11	C	153	C,T	63,36	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	107	94.39	Pasteurella_multocida_16S.l15.c30.ctg.4	107	145.3	0	.	n	.	0	A303G	SNP	303	303	A	9	9	G	66	G	63	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	107	94.39	Pasteurella_multocida_16S.l15.c30.ctg.4	107	145.3	0	.	n	.	0	G375A	SNP	375	375	G	81	81	A	110	A	110	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	107	94.39	Pasteurella_multocida_16S.l15.c30.ctg.4	107	145.3	0	.	n	.	0	G383C	SNP	383	383	G	89	89	C	56	C	56	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	107	94.39	Pasteurella_multocida_16S.l15.c30.ctg.4	107	145.3	0	.	n	.	0	G385C	SNP	385	385	G	91	91	C	36	C	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	107	94.39	Pasteurella_multocida_16S.l15.c30.ctg.4	107	145.3	0	.	n	.	0	C388G	SNP	388	388	C	94	94	G	15	G	15	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4386	Pasteurella_multocida_16S	1551	107	94.39	Pasteurella_multocida_16S.l15.c30.ctg.4	107	145.3	0	.	n	.	0	C394T	SNP	394	394	C	100	100	T	6	T	6	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1192	PmrB_1	1092	1092	99.08	PmrB_1.l6.c30.ctg.1	1451	44.2	0	.	p	.	0	H2R	NONSYN	4	6	CAT	191	193	CGT	33;33;32	C;G;T	33;33;32	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1192	PmrB_1	1092	1092	99.08	PmrB_1.l6.c30.ctg.1	1451	44.2	0	.	p	.	0	V30I	NONSYN	88	90	GTC	275	277	ATC	42;42;44	A;T;C	42;42;44	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1192	PmrB_1	1092	1092	99.08	PmrB_1.l6.c30.ctg.1	1451	44.2	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1034	1036	GGC	58;57;59	G;G;C	58;57;59	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1724	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2049	45.3	0	.	p	.	0	R8S	NONSYN	22	24	AGA	213	215	AGC	16;15;16	A;G;C	15;15;16	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1724	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2049	45.3	0	.	p	.	0	I142L	NONSYN	424	426	ATA	615	617	CTA	49;49;49	C;T;A,G	49;49;48,1	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1724	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2049	45.3	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1134	1136	CAA	55;55;57	C;A;A	55;55;57	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1724	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2049	45.3	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1233	1235	GGT	58;56;56	G;G;T	58;56;56	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1724	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2049	45.3	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1803	1805	GTT	27;26;26	G;T;T	27;25;25	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	896	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1557	31.0	0	.	p	.	0	A125E	NONSYN	373	375	GCA	579	581	GAA	25;25;24	G;A;A	25;25;24	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	896	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1557	31.0	0	.	p	.	0	M185T	NONSYN	553	555	ATG	759	761	ACC	14;15;14	A;C;C	14;15;14	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	896	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1557	31.0	0	.	p	.	0	S225T	NONSYN	673	675	TCC	879	881	ACT	24;25;24	A;C;T	24;25;24	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	896	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1557	31.0	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1269	1271	ATC	21;23;24	A;T;C	21;23;24	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2864	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3628	42.6	0	.	p	.	0	T85I	NONSYN	253	255	ACC	515	517	ATC	43;43;41	A;T;C	43;43;41	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2864	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3628	42.6	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2228	2230	AAG	27;28;29	A;A;G	26;27;29	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1358	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1582	46.2	0	.	p	.	0	A22V	NONSYN	64	66	GCC	286	288	GTC	7;7;7	G;T;C	7;7;7	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1358	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1582	46.2	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1027	1029	TGC	75;75;75	T;G;C	75;75;75	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	2996	acrF	3105	2598	98.5	acrF.l6.c30.ctg.1	3010	53.1	0	.	p	.	0	S46trunc	TRUNC	136	136	T	357	357	T	29	T	29	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	2996	acrF	3105	2598	98.5	acrF.l6.c30.ctg.1	3010	53.1	0	.	p	.	0	G148D	NONSYN	442	444	GGC	663	665	GAC	67;68;69	G;A;C	67;67;68	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	2996	acrF	3105	2598	98.5	acrF.l6.c30.ctg.1	3010	53.1	0	.	p	.	0	F240L	NONSYN	718	720	TTT	939	941	TTA	26;26;26	T;T;A	25;26;26	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	2996	acrF	3105	2598	98.5	acrF.l6.c30.ctg.1	3010	53.1	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1122	1124	AAT	41;41;41	A;A;T	40;41;39	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	2996	acrF	3105	2598	98.5	acrF.l6.c30.ctg.1	3010	53.1	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1909	1909	T	82	T	81	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	2996	acrF	3105	2598	98.5	acrF.l6.c30.ctg.1	3010	53.1	0	HET	.	.	.	T231C	.	231	231	T	452	452	T	67	T,C	57,10	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	820	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1113	39.7	1	SNP	p	R45C	0	.	.	133	135	CGC	381	383	CGC	60;59;59	C;G;C	60;59;59	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	758	acrS	663	663	98.64	acrS.l6.c30.ctg.1	1001	40.8	0	.	p	.	0	L34F	NONSYN	100	102	CTC	265	267	TTC	40;40;40	T;T;C	40;40;40	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	758	acrS	663	663	98.64	acrS.l6.c30.ctg.1	1001	40.8	0	.	p	.	0	E122G	NONSYN	364	366	GAG	529	531	GGG	33;33;32	G;G;G	33;33;32	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	1046	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1212	46.4	0	.	p	.	0	V136L	NONSYN	406	408	GTT	624	626	CTT	65;64;62	C;T;T	65;64;62	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3090	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3052	54.6	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2074	2076	GCA	77;79;80	G;C;A	77;79;80	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3090	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3052	54.6	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2335	2337	ACC	69;72;73	A;C;C	68;72;72	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3090	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3052	54.6	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2644	2646	GCC	49;49;48	G;C;C	49;49;47	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	16	18	arnA_1	1983	107	100.0	arnA_1.l15.c4.ctg.1	107	2.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	610	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1296	25.4	0	.	p	.	0	S221T	NONSYN	661	663	AGC	911	913	ACC	20;20;19	A;C;C	20;19;19	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	610	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1296	25.4	0	.	p	.	0	P225S	NONSYN	673	675	CCG	923	925	TCG	18;16;18	T;C;G	18;16;18	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	618	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1130	29.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1040	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1586	34.1	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1302	1304	AAA	14;14;13	A;A;A	12;13;13	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1040	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1586	34.1	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1314	1316	GAG	13;13;13	G;A;G	11;10;12	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1040	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1586	34.1	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1320	1322	CAC	14;13;12	C;A;C	12;11;11	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1040	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1586	34.1	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1374	1376	GAG	19;18;20	G;A;G	19;18;20	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1502	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1614	49.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	1028	cpxR	699	699	99.43	cpxR.l15.c17.ctg.1	1166	47.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	926	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1336	37.4	0	.	p	.	0	A146T	NONSYN	436	438	GCT	622	624	ACT	34;33;33	A;C;T	34;33;33	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1202	emrA	1173	1173	98.29	emrA.l6.c30.ctg.1	1627	39.7	0	.	p	.	0	I219V	NONSYN	655	657	ATC	875	877	GTC	63;63;61	G;T;C	62;62;61	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1624	emrB	1539	1539	99.87	emrB.l6.c4.ctg.1	2100	41.6	0	.	p	.	0	E197K	NONSYN	589	591	GAA	876	878	AAA	47;49;49	A;A;A	47;48;49	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1012	emrD	1191	1191	98.4	emrD.l6.c4.ctg.1	1638	33.2	0	.	p	.	0	G209S	NONSYN	625	627	GGC	869	871	AGC	27;26;26	A;G;C	27;26;26	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	528	72	emrE_1	333	159	90.57	emrE_1.l15.c30.ctg.1	159	5.1	0	.	p	.	0	I100V	NONSYN	298	300	ATT	144	146	GTC	1;1;1	G;T;C	1;1;1	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1088	emrK	1056	1056	98.2	emrK.l6.c4.ctg.1	1527	38.4	0	.	p	.	0	K176R	NONSYN	526	528	AAG	767	769	AGG	30;31;32	A;G;G	30;31;32	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1088	emrK	1056	1056	98.2	emrK.l6.c4.ctg.1	1527	38.4	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1157	1159	GAC	26;26;25	G;A;C	26;26;25	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	698	emrR	531	531	100.0	emrR.l15.c4.ctg.1	949	39.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1656	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	1998	44.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	670	evgA	615	615	99.19	evgA.l15.c17.ctg.1	1017	35.3	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	389	391	CTG	31;33;32	C;T;G	31;33;32	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	1100	96.91	evgS.l15.c17.ctg.1	1292	31.6	0	.	p	.	0	T38I	NONSYN	112	114	ACA	299	301	ATA	22;21;19	A;T;A	22;21;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	1100	96.91	evgS.l15.c17.ctg.1	1292	31.6	0	.	p	.	0	L42V	NONSYN	124	126	CTA	311	313	GTA	16;17;19	G;T;A	16;17;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	1100	96.91	evgS.l15.c17.ctg.1	1292	31.6	0	.	p	.	0	A93T	NONSYN	277	279	GCG	464	466	ACG	31;31;31	A;C;G	31;31;31	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	1100	96.91	evgS.l15.c17.ctg.1	1292	31.6	0	.	p	.	0	A114E	NONSYN	340	342	GCA	527	529	GAA	32;33;34	G;A;A	32;32;34	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	1100	96.91	evgS.l15.c17.ctg.1	1292	31.6	0	.	p	.	0	T127A	NONSYN	379	381	ACT	566	568	GCT	38;36;37	G;C;T	37;36;37	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	1100	96.91	evgS.l15.c17.ctg.1	1292	31.6	0	.	p	.	0	N133D	NONSYN	397	399	AAT	584	586	GAT	36;38;38	G;A;T	36;38;38	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	1100	96.91	evgS.l15.c17.ctg.1	1292	31.6	0	.	p	.	0	P162S	NONSYN	484	486	CCA	671	673	TCA	23;23;23	T;C;A	23;23;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	1100	96.91	evgS.l15.c17.ctg.1	1292	31.6	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	800	802	CAG	29;29;30	C;A;G	28;29;30	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	1100	96.91	evgS.l15.c17.ctg.1	1292	31.6	0	.	p	.	0	I251V	NONSYN	751	753	ATT	938	940	GTT	33;33;36	G;T;T	33;32;36	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	1100	96.91	evgS.l15.c17.ctg.1	1292	31.6	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1094	1096	GAT	12;12;11	G;A;T	12;12;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	1100	96.91	evgS.l15.c17.ctg.1	1292	31.6	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1262	1264	AAT	8;6;6	A;A;T	8;6;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	1100	96.91	evgS.l15.c17.ctg.1	1292	31.6	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1283	1285	TTA	1;1;1	T;T;A	1;1;1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2631	48.6	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	197	199	AAA	30;28;27	A;A;A	30;28;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2631	48.6	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	932	934	CAT	47;49;49	C;A;T	47;49;49	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2631	48.6	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	986	988	CAT	35;34;33	C;A;T	35;33;33	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2631	48.6	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1004	1006	AGA	37;37;37	A;G;A	37;37;37	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2631	48.6	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1019	1021	AAT	40;39;39	A;A;T	40;39;39	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2631	48.6	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1166	1168	TCC	14;13;12	T;C;C	14;13;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2631	48.6	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1331	1333	ATT	33;32;30	A;T;T	33;32;30	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2631	48.6	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1352	1354	GAT	34;30;30	G;A;T	34;30;30	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2631	48.6	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1466	1468	GTT	52;52;51	G;T;T	52;52;51	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	3134	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2631	48.6	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1751	1753	CAC	47;46;46	C;A;C	47;46;46	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	932	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1268	39.5	1	SNP	p	P64S	0	.	.	190	192	CCA	388	390	CCA	67;68;70	C;C;A	67;68;69	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	932	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1268	39.5	1	SNP	p	P64A	0	.	.	190	192	CCA	388	390	CCA	67;68;70	C;C;A	67;68;69	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	932	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1268	39.5	1	SNP	p	P64L	0	.	.	190	192	CCA	388	390	CCA	67;68;70	C;C;A	67;68;69	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	932	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1268	39.5	1	SNP	p	P64H	0	.	.	190	192	CCA	388	390	CCA	67;68;70	C;C;A	67;68;69	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	932	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1268	39.5	1	SNP	p	P64R	0	.	.	190	192	CCA	388	390	CCA	67;68;70	C;C;A	67;68;69	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	746	gadE	528	528	100.0	gadE.l15.c17.ctg.1	938	42.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	202	gadW	729	131	97.71	gadW.l6.c30.ctg.1	134	33.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	202	gadW	729	300	93.0	gadW.l6.c30.ctg.2	300	10.2	0	.	p	.	0	E54D	NONSYN	160	162	GAA	3	5	GAT	7;8;8	G;A;T	7;8;8	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	202	gadW	729	300	93.0	gadW.l6.c30.ctg.2	300	10.2	0	.	p	.	0	I88M	NONSYN	262	264	ATA	105	107	ATG	3;2;2	A;T;G	3;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	202	gadW	729	300	93.0	gadW.l6.c30.ctg.2	300	10.2	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	108	110	CCG	2;2;2	C;C;G	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	202	gadW	729	300	93.0	gadW.l6.c30.ctg.2	300	10.2	0	.	p	.	0	D100E	NONSYN	298	300	GAC	141	143	GAA	2;2;2	G;A;A	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	202	gadW	729	300	93.0	gadW.l6.c30.ctg.2	300	10.2	0	.	p	.	0	P101S	NONSYN	301	303	CCC	144	146	TCC	2;2;2	T;C;C	1;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	202	gadW	729	300	93.0	gadW.l6.c30.ctg.2	300	10.2	0	.	p	.	0	R102G	NONSYN	304	306	CGG	147	149	GGG	2;2;2	G;G;G	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	202	gadW	729	300	93.0	gadW.l6.c30.ctg.2	300	10.2	0	.	p	.	0	K110N	NONSYN	328	330	AAA	171	173	AAT	4;5;4	A;A;T	4;5;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	790	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1099	38.6	0	.	p	.	0	F53L	NONSYN	157	159	TTC	327	329	TTA	34;32;31	T;T;A	34;32;31	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	790	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1099	38.6	0	.	p	.	0	V79I	NONSYN	235	237	GTT	405	407	ATT	39;37;37	A;T;T	39;37;37	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	790	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1099	38.6	0	.	p	.	0	R246G	NONSYN	736	738	AGA	906	908	GGA	30;29;29	G;G;A	29;29;28	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	790	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1099	38.6	0	.	p	.	0	S248P	NONSYN	742	744	TCG	912	914	CCG	27;25;25	C;C;G	26;24;25	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2988	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3113	51.6	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2278	2280	GAA	55;57;56	G;A;A	54;57;55	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2988	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3113	51.6	1	SNP	p	S83I	0	.	.	247	249	TCG	493	495	TCG	62;62;62	T;C;G	60;60;62	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2988	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3113	51.6	1	SNP	p	S83L	0	.	.	247	249	TCG	493	495	TCG	62;62;62	T;C;G	60;60;62	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2988	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3113	51.6	1	SNP	p	S83W	0	.	.	247	249	TCG	493	495	TCG	62;62;62	T;C;G	60;60;62	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2988	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3113	51.6	1	SNP	p	D87G	0	.	.	259	261	GAC	505	507	GAC	59;57;55	G;A;C	56;55;55	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2988	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3113	51.6	1	SNP	p	D87H	0	.	.	259	261	GAC	505	507	GAC	59;57;55	G;A;C	56;55;55	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2988	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3113	51.6	1	SNP	p	D87N	0	.	.	259	261	GAC	505	507	GAC	59;57;55	G;A;C	56;55;55	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2988	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3113	51.6	1	SNP	p	D87V	0	.	.	259	261	GAC	505	507	GAC	59;57;55	G;A;C	56;55;55	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2988	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3113	51.6	1	SNP	p	D87Y	0	.	.	259	261	GAC	505	507	GAC	59;57;55	G;A;C	56;55;55	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2474	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	2885	46.1	1	SNP	p	R136I	0	.	.	406	408	CGC	602	604	CGC	38;38;37	C;G;C	38;38;37	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2474	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	2885	46.1	1	SNP	p	R136G	0	.	.	406	408	CGC	602	604	CGC	38;38;37	C;G;C	38;38;37	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2474	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	2885	46.1	1	SNP	p	R136E	0	.	.	406	408	CGC	602	604	CGC	38;38;37	C;G;C	38;38;37	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2474	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	2885	46.1	1	SNP	p	R136S	0	.	.	406	408	CGC	602	604	CGC	38;38;37	C;G;C	38;38;37	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2474	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	2885	46.1	1	SNP	p	R136L	0	.	.	406	408	CGC	602	604	CGC	38;38;37	C;G;C	38;38;37	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2474	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	2885	46.1	1	SNP	p	R136H	0	.	.	406	408	CGC	602	604	CGC	38;38;37	C;G;C	38;38;37	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2474	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	2885	46.1	1	SNP	p	R136C	0	.	.	406	408	CGC	602	604	CGC	38;38;37	C;G;C	38;38;37	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	508	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1068	25.6	0	.	p	.	0	A72P	NONSYN	214	216	GCG	452	454	CCG	33;31;29	C;C;G	33;31;28	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	508	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1068	25.6	0	.	p	.	0	T123A	NONSYN	367	369	ACC	605	607	GCC	24;24;25	G;C;C	24;24;25	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1238	leuO	945	945	99.26	leuO.l6.c30.ctg.1	1373	48.6	0	.	p	.	0	P9S	NONSYN	25	27	CCA	233	235	TCA	38;39;39	T,C;C;A	37,1;39;39	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	502	marA	384	384	99.74	marA.l15.c4.ctg.1	800	33.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	246	marR	435	435	97.7	marR.l15.c4.ctg.1	776	17.0	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	506	508	AGC	21;20;20	A,G;G;C	20,1;20;20	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	246	marR	435	435	97.7	marR.l15.c4.ctg.1	776	17.0	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	608	610	CAT	6;6;6	C;A;T	6;5;6	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	246	marR	435	435	97.7	marR.l15.c4.ctg.1	776	17.0	1	SNP	p	V45E	0	.	.	133	135	GTG	332	334	GTG	36;34;34	G;T;G	36;33;34	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	246	marR	435	435	97.7	marR.l15.c4.ctg.1	776	17.0	1	SNP	p	I49S	0	.	.	145	147	ATC	344	346	ATC	29;29;29	A;T;C	29;29;29	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	246	marR	435	435	97.7	marR.l15.c4.ctg.1	776	17.0	1	SNP	p	A70T	0	.	.	208	210	GCA	407	409	GCA	30;30;30	G;C;A	30;29;29	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	246	marR	435	435	97.7	marR.l15.c4.ctg.1	776	17.0	1	SNP	p	R73C	0	.	.	217	219	CGT	416	418	CGT	31;31;31	C;G;T	31;31;30	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	246	marR	435	435	97.7	marR.l15.c4.ctg.1	776	17.0	1	SNP	p	R73S	0	.	.	217	219	CGT	416	418	CGT	31;31;31	C;G;T	31;31;30	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	246	marR	435	435	97.7	marR.l15.c4.ctg.1	776	17.0	1	SNP	p	R77L	0	.	.	229	231	CGC	428	430	CGC	25;24;24	C;G;C	25;23;24	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	246	marR	435	435	97.7	marR.l15.c4.ctg.1	776	17.0	1	SNP	p	R77C	0	.	.	229	231	CGC	428	430	CGC	25;24;24	C;G;C	25;23;24	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	246	marR	435	435	97.7	marR.l15.c4.ctg.1	776	17.0	1	SNP	p	L78M	0	.	.	232	234	CTG	431	433	CTG	23;23;20	C;T;G	23;22;20	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	246	marR	435	435	97.7	marR.l15.c4.ctg.1	776	17.0	1	SNP	p	R94H	0	.	.	280	282	CGC	479	481	CGC	17;17;19	C;G;C	17;17;19	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	246	marR	435	435	97.7	marR.l15.c4.ctg.1	776	17.0	1	SNP	p	R94S	0	.	.	280	282	CGC	479	481	CGC	17;17;19	C;G;C	17;17;19	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	246	marR	435	435	97.7	marR.l15.c4.ctg.1	776	17.0	1	SNP	p	V96E	0	.	.	286	288	GTA	485	487	GTA	20;20;20	G;T;A	20;20;20	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	528	812	mdfA	1233	1104	97.46	mdfA.l15.c30.ctg.1	1324	30.6	0	.	p	.	0	E52D	NONSYN	154	156	GAG	39	41	GAT	12;12;12	G;A;T	12;12;12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	528	812	mdfA	1233	1104	97.46	mdfA.l15.c30.ctg.1	1324	30.6	0	.	p	.	0	N59T	NONSYN	175	177	AAC	60	62	ACC	14;13;13	A;C;C	14;13;13	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	528	812	mdfA	1233	1104	97.46	mdfA.l15.c30.ctg.1	1324	30.6	0	.	p	.	0	I68L	NONSYN	202	204	ATA	87	89	TTA	22;21;18	T;T;A	22;21;18	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	528	812	mdfA	1233	1104	97.46	mdfA.l15.c30.ctg.1	1324	30.6	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	228	230	CAG	42;42;41	C;A;G	41;42;41	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	528	812	mdfA	1233	1104	97.46	mdfA.l15.c30.ctg.1	1324	30.6	0	.	p	.	0	D128A	NONSYN	382	384	GAC	267	269	GCC	26;26;26	G;C;C	26;26;26	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	528	812	mdfA	1233	1104	97.46	mdfA.l15.c30.ctg.1	1324	30.6	0	.	p	.	0	S163A	NONSYN	487	489	TCG	372	374	GCG	29;28;29	G;C;G	28;28;28	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	528	812	mdfA	1233	1104	97.46	mdfA.l15.c30.ctg.1	1324	30.6	0	.	p	.	0	L231V	NONSYN	691	693	CTT	576	578	GTT	15;15;15	G;T;T	12;12;13	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	528	812	mdfA	1233	1104	97.46	mdfA.l15.c30.ctg.1	1324	30.6	0	.	p	.	0	R285fs	FSHIFT	853	853	C	738	738	C	19	C	19	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	882	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1646	28.7	0	.	p	.	0	V12trunc	TRUNC	34	34	G	229	229	G	42	G	42	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	882	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1646	28.7	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	286	288	CAG	17;18;17	C;A;G	17;18;17	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	882	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1646	28.7	0	.	p	.	0	T83I	NONSYN	247	249	ACC	436	438	ATC	24;22;21	A;T;C	24;21;21	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	882	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1646	28.7	0	.	p	.	0	I99M	NONSYN	295	297	ATA	484	486	ATG	18;18;18	A;T;G	18;18;18	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	882	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1646	28.7	0	.	p	.	0	A130T	NONSYN	388	390	GCC	577	579	ACC	27;27;27	A;C;C	27;27;27	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	882	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1646	28.7	0	.	p	.	0	P257T	NONSYN	769	771	CCG	958	960	ACG	38;39;39	A;C;G	38;39;39	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2956	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3386	47.0	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1916	1918	ACC	67;65;64	A;C;C	67;65;63	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2956	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3386	47.0	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2309	2311	CAA	50;50;50	C;A;A	50;47;47	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2956	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3386	47.0	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2477	2479	ATT	41;41;41	A;T;T	41;41;41	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2956	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3386	47.0	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2561	2563	GTT	35;34;33	G;T;T	35;34;33	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2956	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3386	47.0	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2669	2671	GAG	26;26;26	G;A;G	26;26;26	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2956	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3386	47.0	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2897	2899	ATG	23;23;24	A;T;G	23;22;24	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2956	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3386	47.0	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3032	3034	GAT	39;41;40	G;A;T	38;41;40	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2676	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3311	43.0	0	.	p	.	0	I46M	NONSYN	136	138	ATC	317	319	ATG	21;23;24	A;T;G	20;23;24	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2676	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3311	43.0	0	.	p	.	0	V208I	NONSYN	622	624	GTC	803	805	ATC	57;58;62	A;T;C	56;57;61	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2676	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3311	43.0	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3119	3121	CAC	7;7;7	C;A;C	6;7;6	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2676	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3311	43.0	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3122	3124	CTC	7;6;6	C;T;C	6;5;5	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1236	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1841	36.1	0	.	p	.	0	D3E	NONSYN	7	9	GAT	230	232	GAA	22;22;22	G;A;A	22;22;21	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1236	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1841	36.1	0	.	p	.	0	T226A	NONSYN	676	678	ACG	899	901	GCG	44;45;46	G;C;G	44;45;46	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1236	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1841	36.1	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1241	1243	ATC	48;46;47	A;T;C	45;46;47	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1236	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1841	36.1	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1544	1546	TTT	57;59;58	T;T;T	57;59;58	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1520	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1660	49.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3910	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3519	59.8	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1088	1090	ACC	32;32;31	A;C,A;C	32;27,1;29	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3910	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3519	59.8	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2330	2332	GAC	80;79;79	G;A;C	80;79;78	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1202	mdtG	1227	1047	99.33	mdtG.l15.c4.ctg.1	1465	35.6	0	.	p	.	0	V200I	NONSYN	598	600	GTC	609	611	ATC	33;33;35	A;T;C	33;33;35	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1202	mdtG	1227	182	99.45	mdtG.l15.c4.ctg.2	600	20.4	0	.	p	.	0	E5G	NONSYN	13	15	GAA	194	196	GGA	20;21;21	G;G;A	20;20;20	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1036	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1575	35.4	0	.	p	.	0	G134C	NONSYN	400	402	GGT	578	580	TGT	53;53;52	T;G;T	53;53;52	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1036	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1575	35.4	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1148	1150	TTG	32;31;29	T;T;G	32;31;29	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1036	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1575	35.4	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1358	1360	ACG	15;15;16	A;C;G	15;15;16	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1404	mdtL	1176	1176	98.38	mdtL.l15.c30.ctg.1	1633	46.3	0	.	p	.	0	A185S	NONSYN	553	555	GCC	767	769	TCC	48;52;50	T;C;C	47;52;50	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	834	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1471	30.4	0	.	p	.	0	V119I	NONSYN	355	357	GTT	554	556	ATT	28;29;29	A;T;T	28;29;29	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2070	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2427	45.8	0	.	p	.	0	V11M	NONSYN	31	33	GTG	214	216	ATG	25;25;27	A;T;G	23;25;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2070	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2427	45.8	0	.	p	.	0	T33I	NONSYN	97	99	ACC	280	282	ATC	36;34;35	A;T;C	36;34;35	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2070	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2427	45.8	0	.	p	.	0	C116R	NONSYN	346	348	TGC	529	531	CGC	67;66;65	C;G;C	66;66;64	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2070	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2427	45.8	0	.	p	.	0	N238S	NONSYN	712	714	AAC	895	897	AGC	44;44;43	A;G;C	44;43;42	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2070	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2427	45.8	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1096	1098	GTG	39;39;40	G;T;G	38;37;40	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2070	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2427	45.8	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1159	1161	AAC	15;15;14	A;A;C	14;14;14	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2070	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2427	45.8	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1204	1206	GTC	32;32;31	G;T;C	31;31;31	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2070	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2427	45.8	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1234	1236	ATA	61;62;60	A;T;A	61;61;59	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2070	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2427	45.8	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1342	1344	TCT	39;40;41	T;C;T	39;39;41	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2070	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2427	45.8	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1729	1731	GCG	48;48;48	G;C;G	48;47;47	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2070	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2427	45.8	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1942	1944	ATC	45;44;43	A;T;C	45;44;43	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1090	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1804	32.4	0	.	p	.	0	S129A	NONSYN	385	387	TCA	575	577	GCG	42;41;42	G;C;G	42;41;42	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1090	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1804	32.4	0	.	p	.	0	A187T	NONSYN	559	561	GCC	749	751	ACC	34;34;34	A;C;C	34;34;34	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1090	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1804	32.4	0	.	p	.	0	H211R	NONSYN	631	633	CAC	821	823	CGC	35;36;36	C;G;C	35;36;36	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1090	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1804	32.4	0	.	p	.	0	V250A	NONSYN	748	750	GTT	938	940	GCT	39;40;39	G;C;T	39;39;39	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1090	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1804	32.4	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1022	1024	AAA	23;23;23	A;A;A	23;23;23	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1090	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1804	32.4	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1040	1042	CGA	27;24;25	C;G;A	27;24;24	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1090	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1804	32.4	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1205	1207	GCC	29;29;30	G;C;C	29;29;30	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1090	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1804	32.4	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1217	1219	GAT	31;32;32	G;A;T	31;32;32	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1090	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1804	32.4	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1634	1636	GCT	9;9;8	G;C;T	9;9;8	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3074	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3898	42.4	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1539	1541	AAG	39;39;38	A;A;G	39;39;38	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3074	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3898	42.4	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2616	2618	CTG	43;41;41	C;T;G	43;41;41	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	258	mgrB	144	144	100.0	mgrB.l15.c30.ctg.3	168	41.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2236	msbA	1749	1749	98.68	msbA.l6.c30.ctg.1	2186	55.1	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1003	1005	AAC	45;47;47	A;A;C	45;44;46	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2236	msbA	1749	1749	98.68	msbA.l6.c30.ctg.1	2186	55.1	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1549	1551	ATA	77;79;79	A;T;A	77;79;79	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1476	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1634	48.7	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1297	1299	GAT	63;63;66	G;A;T	63;62;65	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1476	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1634	48.7	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1300	1302	CTG	65;63;61	C;T;G	65;62;60	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	610	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1155	28.4	0	.	p	.	0	R27C	NONSYN	79	81	CGT	276	278	TGT	37;36;36	T;G;T	37;36;36	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	610	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1155	28.4	0	.	p	.	0	I117T	NONSYN	349	351	ATC	546	548	ACC	35;35;39	A;C;C	35;35;39	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	610	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1155	28.4	0	.	p	.	0	Q182trunc	TRUNC	544	544	C	741	741	T	17	T	17	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	610	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1155	28.4	0	.	p	.	0	G187D	NONSYN	559	561	GGC	756	758	GAC	14;14;14	G;A;C	14;14;14	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	610	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1155	28.4	1	SNP	p	R15C	0	.	.	43	45	CGC	240	242	CGC	53;52;53	C;G;C	53;52;53	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	610	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1155	28.4	1	SNP	p	S33R	0	.	.	97	99	AGC	294	296	AGC	33;33;32	A;G;C	33;33;32	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	610	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1155	28.4	1	SNP	p	G131D	0	.	.	391	393	GGC	588	590	GGC	35;34;33	G;G;C	35;34;32	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	610	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1155	28.4	1	SNP	p	R203C	0	.	.	607	609	CGT	804	806	CGT	36;36;36	C;G,A;T	36;35,1;36	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	610	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1155	28.4	1	SNP	p	R203L	0	.	.	607	609	CGT	804	806	CGT	36;36;36	C;G,A;T	36;35,1;36	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1578	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1488	57.1	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1127	1129	GAG	99;95;93	G;A;G	99;95;93	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1578	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1488	57.1	1	SNP	p	G141D	0	.	.	421	423	GGT	614	616	GGT	65;63;64	G;G;T	65;62;64	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1578	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1488	57.1	1	SNP	p	G141E	0	.	.	421	423	GGT	614	616	GGT	65;63;64	G;G;T	65;62;64	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1578	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1488	57.1	1	SNP	p	R154A	0	.	.	460	462	CGT	653	655	CGT	77;80;79	C;G;T	77;80;79	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1578	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1488	57.1	1	SNP	p	R154D	0	.	.	460	462	CGT	653	655	CGT	77;80;79	C;G;T	77;80;79	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2658	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2621	54.5	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1786	1788	GTG	59;59;60	G;T;G	59;58;60	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2658	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2621	54.5	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1813	1815	TCG	54;53;51	T;C;G	47;49;50	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2658	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2621	54.5	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2428	2430	AAC	36;36;36	A;A;C	35;36;36	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2658	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2621	54.5	1	SNP	p	A85T	0	.	.	253	255	GCG	442	444	GCG	60;58;56	G;C;G	56;56;52	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2658	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2621	54.5	1	SNP	p	D111H	0	.	.	331	333	GAT	520	522	GAT	40;42;42	G;A;T	40;42;42	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2658	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2621	54.5	1	SNP	p	S129P	0	.	.	385	387	TCC	574	576	TCC	49;50;53	T;C;C	47;49;53	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1726	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2149	42.2	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1451	1453	AAC	42;43;45	A;A;C	42;43;45	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1726	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2149	42.2	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1460	1462	GAT	45;45;43	G;A;T	45;45;43	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1482	patA	1380	1380	99.78	patA.l15.c17.ctg.1	1793	44.4	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	805	807	CAG	47;48;49	C;A;G	47;48;49	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1482	patA	1380	1380	99.78	patA.l15.c17.ctg.1	1793	44.4	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1279	1281	GAT	60;57;55	G;A;T	60;57;54	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	5386	rpoB	4029	4029	98.98	rpoB.l15.c30.ctg.1	4509	64.4	0	.	p	.	0	P372L	NONSYN	1114	1116	CCT	1364	1366	CTT	57;57;57	C;T,C;T	48;56,1;54	.	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	5386	rpoB	4029	4029	98.98	rpoB.l15.c30.ctg.1	4509	64.4	1	SNP	p	V146F	0	.	.	436	438	GTT	686	688	GTT	72;72;68	G;T;T	72;72;68	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	5386	rpoB	4029	4029	98.98	rpoB.l15.c30.ctg.1	4509	64.4	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1787	1789	CAG	55;57;59	C;A;G	54;57;59	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	5386	rpoB	4029	4029	98.98	rpoB.l15.c30.ctg.1	4509	64.4	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1787	1789	CAG	55;57;59	C;A;G	54;57;59	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	5386	rpoB	4029	4029	98.98	rpoB.l15.c30.ctg.1	4509	64.4	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1826	1828	CAC	61;62;62	C;A;C	61;62;62	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	5386	rpoB	4029	4029	98.98	rpoB.l15.c30.ctg.1	4509	64.4	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1835	1837	CGT	59;58;58	C;G;T	59;58;58	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	5386	rpoB	4029	4029	98.98	rpoB.l15.c30.ctg.1	4509	64.4	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1835	1837	CGT	59;58;58	C;G;T	59;58;58	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	5386	rpoB	4029	4029	98.98	rpoB.l15.c30.ctg.1	4509	64.4	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1841	1843	TCC	59;56;54	T;C;C	59;56;54	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	5386	rpoB	4029	4029	98.98	rpoB.l15.c30.ctg.1	4509	64.4	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1847	1849	CTC	53;52;52	C;T;C	53;52;52	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	5386	rpoB	4029	4029	98.98	rpoB.l15.c30.ctg.1	4509	64.4	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1937	1939	ACC	65;65;66	A;C;C	65;65;66	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	5386	rpoB	4029	4029	98.98	rpoB.l15.c30.ctg.1	4509	64.4	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1940	1942	CCT	62;61;62	C;C;T	62;61;62	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	5386	rpoB	4029	4029	98.98	rpoB.l15.c30.ctg.1	4509	64.4	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2309	2311	CGT	111;112;108	C;G;T	111;111;107	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	0	.	n	.	0	A226G	SNP	226	226	A	382	382	G	520	G	520	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	1	SNP	n	A794G	0	.	.	794	794	A	950	950	A	348	A	344	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	1	SNP	n	A794T	0	.	.	794	794	A	950	950	A	348	A	344	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	1	SNP	n	G926T	0	.	.	926	926	G	1082	1082	G	370	G	370	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	1	SNP	n	G926C	0	.	.	926	926	G	1082	1082	G	370	G	370	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	1	SNP	n	G926A	0	.	.	926	926	G	1082	1082	G	370	G	370	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	0	HET	.	.	.	G232A	.	232	232	G	388	388	G	508	G,A	420,86	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	0	HET	.	.	.	G1002A,C	.	1002	1002	G	1158	1158	G	307	G,A,C	224,82,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	0	HET	.	.	.	C578T	.	578	578	C	734	734	C	342	C,T	297,43	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	0	HET	.	.	.	G1006C	.	1006	1006	G	1162	1162	G	294	G,C	217,73	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	0	HET	.	.	.	A79G	.	79	79	A	235	235	A	398	A,G	311,83	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	0	HET	.	.	.	C719T	.	719	719	C	875	875	C	314	C,T	182,131	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	0	HET	.	.	.	T273A	.	273	273	T	429	429	T	412	T,A	302,100	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	0	HET	.	.	.	C477A	.	477	477	C	633	633	C	381	C,A	330,48	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	0	HET	.	.	.	C183T	.	183	183	C	339	339	C	401	C,T	276,122	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	0	HET	.	.	.	T90C	.	90	90	T	246	246	T	391	T,C	313,76	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	0	HET	.	.	.	A250T	.	250	250	A	406	406	A	474	A,T	359,111	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	0	HET	.	.	.	G474A	.	474	474	G	630	630	G	395	G,A	289,102	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	0	HET	.	.	.	A253T	.	253	253	A	409	409	A	476	A,T	365,109	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	1090	99.91	rrsB+.l15.c17.ctg.1	1246	337.1	0	HET	.	.	.	C194T	.	194	194	C	350	350	C	403	C,T	326,73	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.2	727	334.4	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	386	A	384	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.2	727	334.4	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	386	A	384	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.2	727	334.4	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	386	A	384	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	111	93.75	rrsB+.l15.c17.ctg.4	111	35.4	0	.	n	.	0	G1002A	SNP	1002	1002	G	25	25	A	73	A	67	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	111	93.75	rrsB+.l15.c17.ctg.4	111	35.4	0	.	n	.	0	G1006C	SNP	1006	1006	G	29	29	C	75	C	69	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	111	93.75	rrsB+.l15.c17.ctg.4	111	35.4	0	.	n	.	0	T1010C	SNP	1010	1010	T	33	33	C	75	C	70	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	111	93.75	rrsB+.l15.c17.ctg.4	111	35.4	0	.	n	.	0	A1019.	DEL	1019	1019	A	41	41	G	74	G	70	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	111	93.75	rrsB+.l15.c17.ctg.4	111	35.4	0	.	n	.	0	.1023G	INS	1023	1023	T	46	46	G	71	G	70	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	12790	rrsB+	1542	111	93.75	rrsB+.l15.c17.ctg.4	111	35.4	0	.	n	.	0	C1038T	SNP	1038	1038	C	61	61	T	41	T	41	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	572	soxR	465	465	100.0	soxR.l15.c4.ctg.1	839	36.6	1	SNP	p	R20H	0	.	.	58	60	CGC	242	244	CGC	53;53;54	C;G;C	53;52;54	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	572	soxR	465	465	100.0	soxR.l15.c4.ctg.1	839	36.6	1	SNP	p	G121D	0	.	.	361	363	GGT	545	547	GGT	50;50;51	G;G;T	50;50;51	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	456	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	787	31.2	1	SNP	p	A12S	0	.	.	34	36	GCA	265	267	GCA	47;47;46	G;C;A	47;47;45	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tetB.3000166.AB089595.0_1206.325	tetB.3000166.AB089595.0_1206.325	1	0	16	16	tet-	1206	139	100.0	tet-.l6.c30.ctg.1	139	1.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tet(B) is a tetracycline efflux protein expressed in many Gram-negative bacteria. It confers resistance to tetracycline, doxycycline, and minocycline, but not tigecycline.;tetB
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1906	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	1901	54.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
